Figure 1. TMem cells augment naive cell phenotypic maturation during priming.
(A) Experimental design and representative FACS plot showing the generation and isolation of vaccine-induced pmel-1 Ly5.1+CD8+ TCM (CD44+CD62L+) and TEM (CD44+CD62L–) cell subsets by adoptive transfer of pmel-1 cells (106) into Ly5.2+ WT hosts followed by rVV-gp100 vaccination (2 × 107 pfu). (B) Representative FACS plots and (C) summary bar graphs demonstrating the distribution of Thy1.1+ TN-derived TSCM (CD44loCD62L+Sca1+CD122+) and TEM cell subsets 6 days following ex vivo expansion alone or in the presence of a 1:1 mixture with Ly5.2+ TCM or TEM cells using CD3/CD28-specific antibodies and IL-2. (D) Representative FACS plots and (E) summary graph demonstrating the distribution of Thy1.1+ TN-derived subsets 6 days following ex vivo expansion alone or in the presence of titrated ratios with Ly5.1+ bulk (CD44+) TMem cells using CD3/CD28-specific antibodies and IL-2. Results in A–E are shown after gating on live+CD8+Thy1.1+ lymphocytes and are representative of 2 independently performed experiments. Results in C and E are presented as mean ± SEM with n = 3 per condition. Statistical comparisons performed using an unpaired 2-tailed Student’s t test corrected for multiple comparisons by a Bonferroni adjustment. ***P < 0.001.